96 related articles for article (PubMed ID: 19462940)
1. Covalent binding of penicillamine to macrophages: implications for penicillamine-induced autoimmunity.
Li J; Mannargudi B; Uetrecht JP
Chem Res Toxicol; 2009 Jul; 22(7):1277-84. PubMed ID: 19462940
[TBL] [Abstract][Full Text] [Related]
2. D-penicillamine-induced autoimmunity: relationship to macrophage activation.
Li J; Uetrecht JP
Chem Res Toxicol; 2009 Sep; 22(9):1526-33. PubMed ID: 19575532
[TBL] [Abstract][Full Text] [Related]
3. Involvement of T helper 17 cells in D-penicillamine-induced autoimmune disease in Brown Norway rats.
Zhu X; Li J; Liu F; Uetrecht JP
Toxicol Sci; 2011 Apr; 120(2):331-8. PubMed ID: 21227906
[TBL] [Abstract][Full Text] [Related]
4. D-penicillamine-induced autoimmunity in the Brown Norway rat: role for both T and non-T splenocytes in adoptive transfer of tolerance.
Séguin B; Masson MJ; Uetrecht J
Chem Res Toxicol; 2004 Oct; 17(10):1299-302. PubMed ID: 15487889
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in a model of D-penicillamine-induced autoimmunity in the Brown Norway rat: predictive value of early signs of danger.
Séguin B; Boutros PC; Li X; Okey AB; Uetrecht JP
Chem Res Toxicol; 2005 Aug; 18(8):1193-202. PubMed ID: 16097792
[TBL] [Abstract][Full Text] [Related]
6. Current trends in drug-induced autoimmunity.
Uetrecht J
Autoimmun Rev; 2005 Jun; 4(5):309-14. PubMed ID: 15990079
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the involvement of macrophages and T cells in D-penicillamine-induced autoimmunity in the Brown Norway rat.
Masson MJ; Teranishi M; Shenton JM; Uetrecht JP
J Immunotoxicol; 2004 Apr; 1(2):79-93. PubMed ID: 18958641
[TBL] [Abstract][Full Text] [Related]
8. Animal models of idiosyncratic drug reactions.
Shenton JM; Chen J; Uetrecht JP
Chem Biol Interact; 2004 Nov; 150(1):53-70. PubMed ID: 15522261
[TBL] [Abstract][Full Text] [Related]
9. Tolerance induced by low dose D-penicillamine in the brown Norway rat model of drug-induced autoimmunity is immune-mediated.
Masson MJ; Uetrecht JP
Chem Res Toxicol; 2004 Jan; 17(1):82-94. PubMed ID: 14727922
[TBL] [Abstract][Full Text] [Related]
10. Protein N-acylation: H2O2-mediated covalent modification of protein by lipid peroxidation-derived saturated aldehydes.
Ishino K; Shibata T; Ishii T; Liu YT; Toyokuni S; Zhu X; Sayre LM; Uchida K
Chem Res Toxicol; 2008 Jun; 21(6):1261-70. PubMed ID: 18512967
[TBL] [Abstract][Full Text] [Related]
11. Covalent binding of rofecoxib, but not other cyclooxygenase-2 inhibitors, to allysine aldehyde in elastin of human aorta.
Oitate M; Hirota T; Murai T; Miura S; Ikeda T
Drug Metab Dispos; 2007 Oct; 35(10):1846-52. PubMed ID: 17620346
[TBL] [Abstract][Full Text] [Related]
12. D-penicillamine-induced granulomatous hepatitis in brown Norway rats.
Metushi IG; Zhu X; Uetrecht J
Mol Cell Biochem; 2014 Aug; 393(1-2):229-35. PubMed ID: 24771069
[TBL] [Abstract][Full Text] [Related]
13. Role of drug metabolism for breaking tolerance and the localization of drug hypersensitivity.
Uetrecht J
Toxicology; 2005 Apr; 209(2):113-8. PubMed ID: 15767022
[TBL] [Abstract][Full Text] [Related]
14. Rapid, hydrolytically stable modification of aldehyde-terminated proteins and phage libraries.
Kitov PI; Vinals DF; Ng S; Tjhung KF; Derda R
J Am Chem Soc; 2014 Jun; 136(23):8149-52. PubMed ID: 24848432
[TBL] [Abstract][Full Text] [Related]
15. Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection.
Burcham PC; Pyke SM
Mol Pharmacol; 2006 Mar; 69(3):1056-65. PubMed ID: 16368895
[TBL] [Abstract][Full Text] [Related]
16. Immunogenetically controlled autoimmune reactions induced by mercury, gold and D-penicillamine in laboratory animals: a review from the vantage point of premarketing safety studies.
Balazs T
Toxicol Ind Health; 1987 Sep; 3(3):331-6. PubMed ID: 3317993
[TBL] [Abstract][Full Text] [Related]
17. Bioactivation of minocycline to reactive intermediates by myeloperoxidase, horseradish peroxidase, and hepatic microsomes: implications for minocycline-induced lupus and hepatitis.
Mannargudi B; McNally D; Reynolds W; Uetrecht J
Drug Metab Dispos; 2009 Sep; 37(9):1806-18. PubMed ID: 19505990
[TBL] [Abstract][Full Text] [Related]
18. Assessment of autoimmunity-inducing potential using the brown Norway rat challenge model.
White KL; David DW; Butterworth LF; Klykken PC
Toxicol Lett; 2000 Mar; 112-113():443-51. PubMed ID: 10720764
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of the disease-modifying anti-arthritic thiol agents D-penicillamine and sodium aurothiomalate: restoration of cellular free thiols and sequestration of reactive aldehydes.
Wood PL; Khan MA; Moskal JR
Eur J Pharmacol; 2008 Feb; 580(1-2):48-54. PubMed ID: 18022616
[TBL] [Abstract][Full Text] [Related]
20. Idiosyncratic drug reactions: past, present, and future.
Uetrecht J
Chem Res Toxicol; 2008 Jan; 21(1):84-92. PubMed ID: 18052104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
